Acquisition of Nora Pharma Inc. (Details Narrative)				12 Months Ended
	Apr. 22, 2024 USD ($)	Apr. 22, 2024 CAD ($)	Oct. 20, 2022 USD ($) shares	Dec. 31, 2023 USD ($)	Dec. 31, 2023 CAD ($)	Sep. 30, 2024 USD ($)	Oct. 20, 2022 CAD ($)
Business Acquisition [Line Items]
Earnout payable				$ 2,547,831		$ 0
Nora Pharma [Member]
Business Acquisition [Line Items]
Purchase price of shares			$ 18,860,637
Payments to acquire shares			$ 14,346,637
Stock issued for acquisition | shares			1,850
Stock issued for acquisition, value			$ 4,514,000
Earnout liability expense, first installment	$ 2,291,761	$ 3,093,878
Earnout liability expense, second installment				354,968	$ 479,207
Nora Pharma [Member] | Malek Chamoun [Member]
Business Acquisition [Line Items]
Earnout payable			$ 3,632,000				$ 5,000,000
Payment of earnout liability				$ 1,084,169